Brief: Ascelia Pharma Receives Conditional FDA Acceptance For Brand Name Orviglance

Ascelia Pharma AB

10/08/2021 08:33

Aug 10 (Reuters) - Ascelia Pharma AB  ACELP.ST :
    * ASCELIA PHARMA RECEIVES CONDITIONAL FDA ACCEPTANCE FOR
BRAND
NAME ORVIGLANCE

Source text for Eikon:  ID:nMFN1xcXYM 
Further company coverage:  ACELP.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))